Multi-species plasmids and K. pneumoniae clonal spread contribute to bla NDM outbreak across seven UK healthcare sites

Authors:

Abstract
Objectives: The NDM carbapenemase enables Gram-negative bacteria to hydrolyse almost all β-lactam antibiotics. In 2023, a large increase of blaNDM in clinical isolates was identified in a clinical microbiology laboratory serving hospitals and GP practices in Merseyside, UK, raising concerns of a larger outbreak. Methods: We used short-read WGS and bioinformatic analyses to identify the outbreak(s) and identify potential links by combining with anonymized, routinely collected clinical metadata. A subset of isolates were long-read sequenced to analyse resistance genes and plasmids at maximum resolution. Results: The outbreak included Enterobacter hormaechei, Klebsiella pneumoniae, Escherichia coli, Citrobacter freundii, Citrobacter braakii and Enterobacter kobei and 28 STs. K. pneumoniae ST101 represented the only major clonal expansion (18/21 K. pneumoniae isolates), and combination with metadata strongly suggested a multi-site hospital-associated outbreak. We identified four variants of blaNDM, and long-read sequencing indicated blaNDM-1 spread across species was driven by an IncHI2/IncHI2A plasmid, representing 82% of blaNDM1 isolates. Conclusions: This study captured an outbreak of blaNDM-positive Enterobacterales across eight healthcare settings and highlights the complex epidemiology of spread mediated by both expansion of successful lineages (K. pneumoniae ST101) and multi-species plasmids (IncHI2/IncHI2A). It also highlights the challenge of recognizing and tracing an outbreak linked to patients moving across different healthcare systems and the importance of linked surveillance systems.
Funding Information
  • Academy of Medical Sciences (SBF009/1181)

This publication has 18 references indexed in Scilit: